C

Covetrus Inc
F:2NJ

Watchlist Manager
Covetrus Inc
F:2NJ
Watchlist
Price: 21.52 EUR 0.19%
Market Cap: €3B

Net Margin

-0.3%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-0.3%
=
Net Income
$-13m
/
Revenue
$4.6B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-0.3%
=
Net Income
€-13m
/
Revenue
$4.6B

Peer Comparison

Country Company Market Cap Net
Margin
US
Covetrus Inc
F:2NJ
3B EUR
Loading...
US
Mckesson Corp
NYSE:MCK
101.7B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
68.4B USD
Loading...
US
Cencora Inc
NYSE:COR
68.6B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
49.6B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.2B AUD
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
66.1B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.2B USD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.9B CNY
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
64.5B HKD
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
40th
Based on 15 072 companies
40th percentile
-0.3%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Covetrus Inc
Glance View

Market Cap
3B EUR
Industry
Health Care

Nestled in the heart of the animal health industry, Covetrus Inc. emerged as a formidable force, blending technological expertise with deep-rooted veterinary knowledge. Created in 2019 through the merger of Henry Schein Animal Health and Vets First Choice, this company has swiftly positioned itself as an essential partner for veterinary practitioners. Covetrus provides a comprehensive suite of services designed to streamline operations for veterinary clinics, ranging from practice management software to inventory management systems. The core of their operation focuses on enhancing clinic efficiency and improving patient outcomes, driven by digital innovation that connects clinics effortlessly with critical pharmaceuticals, pet foods, and other essential products. Covetrus's business model thrives on a multi-pronged approach. Revenue streams flow widely from the robust sales of prescription and non-prescription medications, medical supplies, and pet products, underpinned by its vast, integrated distribution network. Moreover, the company's software solutions, which are integral to their service offering, generate additional income through subscription fees and service upgrades. This ability to cross-sell digital and physical products creates a cohesive ecosystem for veterinary professionals, ensuring that Covetrus not only meets day-to-day operational needs but also facilitates long-term growth and competitiveness for its customers. Their strategic positioning within the veterinary supply chain, coupled with a clear focus on enhancing clinical workflows, cements Covetrus's role as an indispensable ally in modern animal healthcare.

2NJ Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-0.3%
=
Net Income
$-13m
/
Revenue
$4.6B
How has Net Margin changed over time?

Over the last 3 years, Covetrus Inc’s Net Margin has decreased from 0.8% to -0.3%. During this period, it reached a low of -27.6% on Dec 31, 2019 and a high of 0.8% on May 30, 2019.

Back to Top